The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...

KDOQI (2007) KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 471–530 National ...

The choice of iron preparation in children with iron-deficiency anemia related to chronic kidney disease (CKD) includes tolerance and response.

Anemia is highly prevalent in patients with ... human erythropoietin therapy in anemic patients with chronic kidney disease and concomitant heart disease have demonstrated a reduction in left ...

Vafseo already boasts CKD anemia approvals in both dialysis and nondialysis patients in some countries outside the U.S., but safety concerns raised by the FDA—mainly around cardiovascular risks ...

U.S. Renal Care has now enrolled more than half of the total target of 2,200 patients. Vafseo has been recommended for symptomatic anemia in adults undergoing dialysis for CKD by the United ...

Background: Chronic kidney disease (CKD) has been linked to higher heart failure (HF) risk. Anemia is a common consequence of CKD, and recent evidence suggests that anemia is a risk factor for HF.

“As CKD progresses, patients frequently suffer from malnutrition, anemia, and bone-mineral disorders, all of which significantly impact their overall health and well-being. Nutritional deficiencies, ...

The Phase IIa study is designed to assess the safety, tolerability, and preliminary clinical effects of sevuparin in non-dialysis and dialysis CKD patients with anemia. Opening a second site marks ...